Gastroparesis Registry 4

NCT05846802 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 250

Last updated 2026-04-03

No results posted yet for this study

Summary

The Gastroparesis Registry 4 (GpR4) is an observational study of patients with symptoms of gastroparesis (Gp) and functional dyspepsia (FD) with either delayed or normal gastric emptying. To better understand these disorders, this registry will capture demographic, clinical, physiological, questionnaire, and patient outcome data to characterize the patients and their clinical course. Participants will complete several questionnaires, complete a nutrient drink test and have a gastric emptying study.

Conditions

  • Gastroparesis
  • Gastroparesis Nondiabetic
  • Gastroparesis Due to Diabetes Mellitus Type I
  • Gastroparesis Due to Diabetes Mellitus Type II
  • Functional Disorder of Gastrointestinal Tract
  • Gastro-Intestinal Disorder

Sponsors & Collaborators

  • Texas Tech University Health Sciences Center, El Paso

    collaborator OTHER
  • Temple University

    collaborator OTHER
  • University of Louisville

    collaborator OTHER
  • Mayo Clinic

    collaborator OTHER
  • National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

    collaborator NIH
  • Massachusetts General Hospital

    collaborator OTHER
  • Wake Forest University

    collaborator OTHER
  • Johns Hopkins Bloomberg School of Public Health

    lead OTHER

Principal Investigators

  • Jay Pasricha, MD · Mayo Clinic

  • Henry Parkman, MD · Temple University

  • David Shade, JD · Johns Hopkins Bloomberg School of Public Health

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-09-20
Primary Completion
2027-04-30
Completion
2027-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05846802 on ClinicalTrials.gov